Quoin Pharmaceuticals

ASHBURN, Va., June 16, 2026 Quoin Pharmaceuticals announced a positive clinical update from its ongoing pediatric Netherton Syndrome (NS)...

ASHBURN, Va., April 28, 2026 Quoin Pharmaceuticals Ltd. has announced a major clinical and regulatory update for its QRX009...

Ashburn, Virginia — March 9, 2026 Clinical-stage specialty biopharmaceutical company Quoin Pharmaceuticals Ltd. continues to advance the development of...